003520.KS

Yungjin Pharm. Co., Ltd. [003520.KS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

003520.KS Stock Summary

Top 003520.KS Correlated Resources

003520.KS


Top 10 Correlated ETFs

003520.KS


Top 10 Correlated Stocks

003520.KS


In the News

003520.KS Financial details

Company Rating
Buy
Market Cap
550.5B
Income
-6.67B
Revenue
212.74B
Book val./share
564.68
Cash/share
-
Dividend
-
Dividend %
-
Employees
574
Optionable
No
Shortable
Yes
Earnings
08 May 2023
P/E
-78.85
Forward P/E
-
PEG
-0.16
P/S
2.47
P/B
5.27
P/C
-
P/FCF
-25.09
Quick Ratio
-
Current Ratio
1.9
Debt / Equity
1.04
LT Debt / Equity
-
-
-
EPS (TTM)
-37.2
EPS next Y
-
EPS next Q
-
EPS this Y
8599.07%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
0.11%
Revenue Q/Q
4.17%
EPS Q/Q
48.26%
-
-
-
-
SMA20
-15.48%
SMA50
-8.72%
SMA100
12.23%
Inst Own
-
Inst Trans
-
ROA
-3%
ROE
-7%
ROC
-0.05%
Gross Margin
30%
Oper. Margin
-4%
Profit Margin
-3%
Payout
-
Shs Outstand
182.89M
Shs Float
84.74M
-
-
-
-
Target Price
-
52W Range
2390.0-5670.0
52W High
-47.53%
52W Low
+24.48%
RSI
39
Rel Volume
0.47
Avg Volume
714.9K
Volume
334.01K
Perf Week
-1.16%
Perf Month
-19.27%
Perf Quarter
21.43%
Perf Half Y
8.78%
-
-
-
-
Beta
1.15345
-
-
Volatility
64.53%, 258.16%
Prev Close
-0.17%
Price
2975
Change
-1.33%

003520.KS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
1.07K1.02K1.21K1.14K1.07K
Net income per share
10.22-33.3627.5-0.73-63.33
Operating cash flow per share
17.256.9750.7579.2745.75
Free cash flow per share
-42.9-18.77-5.8844.8-16.14
Cash per share
66.710.033.562.342.54
Book value per share
654.98610.23632.89625.68573.48
Tangible book value per share
612.33597.44620.79617.12565.6
Share holders equity per share
654.98610.23632.89625.68573.48
Interest debt per share
101.9468.779.9941.2172.55
Market cap
1644.08B1086.38B1212.58B1470.46B967.5B
Enterprise value
1658.06B1096.84B1226.56B1477.31B980.1B
P/E ratio
880.26-178.07241.07-11.05K-83.53
Price to sales ratio
8.435.835.57.054.93
POCF ratio
521.64852.61130.63101.43115.62
PFCF ratio
-209.77-316.4-1.13K179.48-327.74
P/B Ratio
13.749.7310.4812.859.22
PTB ratio
13.749.7310.4812.859.22
EV to sales
8.55.885.567.095
Enterprise value over EBITDA
168.284.17K71.95178.54-149.48
EV to operating cash flow
526.07860.82132.14101.9117.13
EV to free cash flow
-211.56-319.44-1.14K180.32-332.01
Earnings yield
0-0.0100-0.01
Free cash flow yield
0000.010
Debt to equity
0.70.760.730.640.85
Debt to assets
0.410.430.420.390.46
Net debt to EBITDA
1.4239.730.820.83-1.92
Current ratio
3.042.882.83.271.86
Interest coverage
6.54-8.0201.51-66.41
Income quality
1.69-0.211.85-108.91-0.72
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.030.030.020.020.02
Research and developement to revenue
0.070.060.060.070.07
Intangibles to total assets
0.040.010.010.010.01
Capex to operating cash flow
-3.49-3.69-1.12-0.43-1.35
Capex to revenue
-0.06-0.03-0.05-0.03-0.06
Capex to depreciation
-1.66-0.71-1.35-0.81-1.53
Stock based compensation to revenue
00000
Graham number
388.17676.76625.8101.23903.97
ROIC
0.01-0.010.030-0.06
Return on tangible assets
0.01-0.030.030-0.06
Graham Net
-282.84-321.27-306.54-259.84-376.83
Working capital
76.55B71.58B71.54B68.53B41.36B
Tangible asset value
111.86B109.27B113.54B112.87B103.44B
Net current asset value
29.82B25.18B26.64B25.01B478.24M
Invested capital
0.150.110.130.060.12
Average receivables
00000
Average payables
14.86B16.02B16.47B11.86B12.83B
Average inventory
42.4B44.26B51.9B53.7B45.54B
Days sales outstanding
00000
Days payables outstanding
36.8456.3735.3827.2641.17
Days of inventory on hand
117.71139.71145.12139.07104.78
Receivables turnover
00000
Payables turnover
9.916.4710.3213.398.87
Inventory turnover
3.12.612.522.623.48
ROE
0.02-0.050.040-0.11
Capex per share
-60.16-25.74-56.63-34.47-61.89

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric History 2021-09-302021-12-312022-03-312022-06-30 2022-09-30
Revenue per share
270.42294.83288.07294.83307.11
Net income per share
-20.83-9.34-8-8-11.86
Operating cash flow per share
46.67-10.71-50.3237.3-7.01
Free cash flow per share
29.4-37.05-89.4725.98-18.37
Cash per share
02.541.914.670
Book value per share
571.71573.48569.3576.59564.68
Tangible book value per share
571.71565.6563.08563.09564.68
Share holders equity per share
571.71573.48569.3576.59564.68
Interest debt per share
071.71162.16145.24-0.5
Market cap
919.95B967.5B944.64B641.25B465.24B
Enterprise value
919.95B980.1B973.62B665.92B465.24B
P/E ratio
-60.36-141.62-162.5-113.28-55.44
Price to sales ratio
18.617.9418.0512.38.56
POCF ratio
107.79-493.98-103.3597.19-375.36
PFCF ratio
171.09-142.8-58.12139.52-143.18
P/B Ratio
8.89.229.136.294.66
PTB ratio
8.89.229.136.294.66
EV to sales
18.618.1818.612.778.56
Enterprise value over EBITDA
-389.74-864.72.25K1.75K-191.48
EV to operating cash flow
107.79-500.41-106.52100.92-375.36
EV to free cash flow
171.09-144.65-59.9144.88-143.18
Earnings yield
00000
Free cash flow yield
0.01-0.01-0.020.01-0.01
Debt to equity
0.770.850.9611.04
Debt to assets
0.430.460.490.50.51
Net debt to EBITDA
0-11.1166.9564.70
Current ratio
2.71.861.682.011.9
Interest coverage
0-50.46-5.97-7.4526.41
Income quality
-2.241.156.29-4.660.59
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.360.020.020.010.33
Research and developement to revenue
00.060.060.060
Intangibles to total assets
00.010.010.010
Capex to operating cash flow
-0.372.460.78-0.31.62
Capex to revenue
-0.06-0.09-0.14-0.04-0.04
Capex to depreciation
-1.75-2.68-3.94-1.07-1.01
Stock based compensation to revenue
00000
Graham number
517.67347.13320.11322.16388.19
ROIC
0.07-0.010-0.01-0.01
Return on tangible assets
-0.02-0.01-0.01-0.01-0.01
Graham Net
-440.03-376.83-430.47-431.63-587.81
Working capital
57.11B41.36B40.4B51.39B48B
Tangible asset value
104.56B103.44B102.29B99.61B99.89B
Net current asset value
10.32B478.24M-160.55M189.26M-2.72B
Invested capital
00.120.280.250
Average receivables
00000
Average payables
6.93B7.79B15.55B18.81B11.04B
Average inventory
24.8B19.83B41.03B45.98B24.78B
Days sales outstanding
00000
Days payables outstanding
03738.5154.760
Days of inventory on hand
094.18105.21122.870
Receivables turnover
00000
Payables turnover
02.432.341.640
Inventory turnover
00.960.860.730
ROE
-0.04-0.02-0.01-0.01-0.02
Capex per share
-17.27-26.34-39.16-11.32-11.36

003520.KS Frequently Asked Questions

What is Yungjin Pharm. Co., Ltd. stock symbol ?

Yungjin Pharm. Co., Ltd. is a KR stock and trading under the symbol 003520.KS

What is Yungjin Pharm. Co., Ltd. stock quote today ?

Yungjin Pharm. Co., Ltd. stock price is $2975 today.

Is Yungjin Pharm. Co., Ltd. stock public?

Yes, Yungjin Pharm. Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Similar Market Cap